Literature DB >> 10970376

Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains.

E Flodgren1, S Bengtsson, M Knutsson, E A Strebkova, A H Kidd, O A Alexeyev, K Kidd-Ljunggren.   

Abstract

Until 1991, the Russian city of Samara was largely isolated from other parts of Russia and the rest of the world. Very recently, Samara has seen an alarming increase in the incidence of hepatitis. The proportion of fulminant cases is unusually high. We wanted to assess the roles of hepatitis B virus (HBV) and hepatitis D virus (HDV) in acute viral hepatitis in this region by analyzing the prevailing strains of both and by determining their genotypes and possible origin. Serum samples were screened for different serological markers and by PCR followed by direct sequencing. Of the 94 HBV-positive samples (80% of which were acute infections), 37 (39%) were also HDV positive. Sixty-seven percent of the patients had anti-HCV antibodies. Twenty-five percent of all patients in the study had fulminant hepatitis. Statistically significant sex differences were found among fulminant cases. For HBV, the core promoter sequences of 62 strains were determined and all but one were found to be of genotype D. None of these had any deletions. Only one strain, from a patient with fulminant fatal hepatitis, showed multiple mutations. The pre-S2 region sequences of 31 HBV strains were also compared. Phylogenetically, these fell into two distinct groups within genotype D, suggesting different origins. For HDV, part of the region encoding the delta-antigen was sequenced from four strains. All proved to be of genotype I and were similar to Far Eastern and Eastern European strains. The contribution of intravenous drug use to the sharp increase in viral hepatitis in this unique setting is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970376      PMCID: PMC87379     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

Review 1.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

2.  Direct sequencing from low-melt agarose with Sequenase.

Authors:  K A Kretz; G S Carson; J S O'Brien
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

3.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Heterogeneity and evolution rates of delta virus RNA sequences.

Authors:  F Imazeki; M Omata; M Ohto
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  Nosocomial transmission of hepatitis B virus infection through multiple-dose vials.

Authors:  K Kidd-Ljunggren; E Broman; H Ekvall; O Gustavsson
Journal:  J Hosp Infect       Date:  1999-09       Impact factor: 3.926

6.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

7.  Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta".

Authors:  K E Ljunggren; M E Patarroyo; R Engle; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

8.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.

Authors:  H Okamoto; F Tsuda; H Sakugawa; R I Sastrosoewignjo; M Imai; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

9.  Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.

Authors:  A G Shattock; F M Irwin; B M Morgan; I B Hillary; M G Kelly; J F Fielding; D A Kelly; D G Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

10.  Fulminant delta hepatitis among Swedish drug addicts.

Authors:  K E Ljunggren; B G Hansson
Journal:  Scand J Infect Dis       Date:  1986
View more
  14 in total

1.  Selecting a genetic region for molecular analysis of hepatitis B virus transmission.

Authors:  Sibnarayan Datta; Arup Banerjee; Partha Kumar Chandra; Runu Chakravarty
Journal:  J Clin Microbiol       Date:  2007-02       Impact factor: 5.948

Review 2.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

3.  Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.

Authors:  Jianrong Li; Jing Wang; Kunlun Tian; Yixin Wang; Lei Zhang; Hanju Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Treatment options for hepatitis delta virus infection.

Authors:  Benjamin Heidrich; Michael P Manns; Heiner Wedemeyer
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 5.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

6.  Clinical presentation and genotype of hepatitis delta in Karachi.

Authors:  Tariq Moatter; Zaigham Abbas; Sabhita Shabir; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

Review 7.  Sexually acquired hepatitis.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

8.  Virological and clinical characteristics of hepatitis delta virus in South Asia.

Authors:  Khalid Mumtaz; Umair S Ahmed; Sadik Memon; Ali Khawaja; Muhammad T Usmani; Tariq Moatter; Saeed Hamid; Wasim Jafri
Journal:  Virol J       Date:  2011-06-20       Impact factor: 4.099

9.  Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Yaser Saiedi Hosseini; Seyed Hossein Aalaei Andabili
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

10.  Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan.

Authors:  Saeeda Baig; Anwar Siddiqui; Runu Chakravarty; Tariq Moatter
Journal:  BMC Res Notes       Date:  2009-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.